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Abstract
Background: Carcinogenesis of adenocarcinoma of the prostate occurs due to dysregulation of zinc level within the
cells. Intracellular zinc molecules influx is regulated by a transporter protein ZIP1, whose non-presence is predicted to
inhibit apoptosis, thus leads to the development of prostate adenocarcinoma. Methods: This study was aimed to analyse
the correlation of ZIP1 and Caspase-3 expression in prostate adenocarcinoma on its grading as represented by Gleason
Score. This was a cross-sectional, retrospective analytical study on 31 Formalin-fixed, paraffin-embedded tissue that
meets inclusion criteria. The specimen was stained using the immune-histochemistry technique for ZIP1 and Caspase-3.
Protein expression of each case was counted using ImageJ analysis. Gleason score was acquired as secondary data from
the cases' reports. The correlation of their expression with respect to Gleason score was analysed with Pearson’s
correlation using SPSS 11.5. Results: Mean expression level of ZIP1 and Caspase-3 in prostate adenocarcinoma were
35% and 33%, respectively. There was a significantly positive correlation between ZIP1 and Caspase-3 expression
(r = 0.379; p = 0.018). However, their correlation was stronger in intermediate-grade group (r = 0.73; p = 0.01) and the
correlation was much weaker in high-grade group (r = 0.04; p = 0.48). Conclusions: There was a positive correlation
between ZIP1 and Caspase-3 expression in prostate adenocarcinoma.
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Based on the various references, it was mentioned that
there is a relationship between protein expression ZIP1
as the gateway of zinc ions into cells that spur apoptosis
and Caspase-3 activation as executor of apoptosis protein
in prostate adenocarcinoma histological grade Gleason
score system. This study aims to determine the role of
transporter proteins in the process of development of
malignancy ZIP1 prostate cancer. Also, this study also
seeks to analyse the level of protein expression and
activation ZIP1 caspase-3 as well as the correlation both
in prostate adenocarcinoma tissues with different Gleason
score.

Introduction
Prostate cancer is one of the most common
malignancies occurring in mention the worldwide, with
increasing incidence especially in developing countries
and is often diagnosed at an advanced stage.1 The
incidence of prostate cancer in Indonesia ranks the third
after lung and colon cancer.2 Because of highly
incidence of prostate cancer in Indonesia, searching the
best therapeutic method for early detection, diagnosis,
and treatment of prostate cancer needs to be done.
The development of prostate cancer occurs due to changes
in the characteristic of cell proliferation and apoptosis.
The normal prostate gland produces fluid, prostatic
secretions that contain a variety of essential cell
proliferation and apoptosis elements such as zinc, citric,
and prostate-specific antigen (PSA) biomarkers.3 The
Accumulation of intracellular zinc influenced zinc
transporters in the plasma membrane and intracellular
membranes. ZIP1 proteins that contained in the
basolateral membrane of the epithelial prostate is a
major transporter of zinc into the cell carrier. Some
research report ZIP1 transport activity and high
accumulation of zinc have influence tumour suppressor
activity guard cells undergone plastic malignancies.4

Methods
The study design was a cross-sectional retrospective
analytical study design. The research subject is a paraffin
block prostate adenocarcinoma which had been diagnosed
by a medical anatomical pathology doctor specialist
with complete data Gleason score (GS). All data contain in
the archive department of pathology-anatomy, Faculty of
Medicine, Universitas Indonesia and Cipto Mangunkusumo
Hospital (RSCM). The specimen was stained using the
immune-histochemistry technique for ZIP1 and Caspase-3.
Based on the Gleason score, subjects were divided into
five groups: GS6, 7GS, GS8, 9GS, and GS10.
18
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Calculation of sample size. The sample size was
calculated using the formula correlation with alpha = 5%
and a confidence level = 95%. Large samples are obtained
as many as 31 samples for each antibody treatment.
Slide preparation and immuno-histochemistry. Paraffin
blocks were taken from patients FKUI based HE
preparations that verified by Anatomical Pathology
specialists. Paraffin blocks were cut with a thickness of
4µm and placed on microscope slides. Slides were dried
in an oven at a temperature of 60 °C for 30 minutes.
Immuno-histochemistry smear using StreptavidinBiotin complex labelling methods. Primary antibodies
were used to label ZIP1 is primary antibody rabbit
polyclonal anti-human ZIP1 (Abcam technologies)
dilution 1 : 2000, while for Caspase-3 used primary
antibody mouse monoclonal anti-human Caspase-3
(Santa Cruz) dilution 1 : 1600. Included negative
control for each case and a positive control for each
batch of staining.

Assessment ZIP1 expression and Caspase 3 conducted
on 500 tumour cells from 5 different visual fields
(magnification 400×) were selected randomly. Each
represents the field of view of 100 tumour cells. Protein
expression tested positive (+) if the chocolate stained
on the cytoplasmic membrane and cytoplasm of tumour
cells to antibody ZIP1 and chocolate stained on the
cytoplasmic Caspase-3 antibodies. Stained cell count
performed using ImageJ program (Figure 1 & Figure 2).
Data analysis using SPSS software version 11.5 are
descriptive statistics, testing normality using the ShapiroWilk test. Comparison of expression profiles ZIP1 and
Caspase-3 prostate cancer tissue in a variety of Gleason
score is used Kruskal-Walis test or Analysis of Variants
(ANOVA). The correlation between the expression of
Caspase-3 ZIP1 and prostate cancer tissue at different
Gleason scores with Pearson correlation testor Spearman
alternative test. Furthermore, the data will be presented
in the form of narratives, images, and tables.

Figure 1. Expression of Negative and Positive Immune-Histochemical Staining in Prostate Adenocarcinoma (Magnification
400x). (a) Negative Expression (b) The Expression of Caspase-3 Positive

Figure 1. Expression of Negative and Positive Immuno-Histochemical Staining in Prostate Adenocarcinoma (Magnification
400x). (a) Negative Expression (b) Expression Positive ZIP1
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Results
This study used 31 cases were confirmed as prostate
adenocarcinoma that comes from prostatectomy outcomes
preparation and meets the inclusion criteria Immunohistochemical examination of the 31 cases studied were
grouped by system Gleason Score (GS) to obtain cases
of adenocarcinoma with GS6 counted 4 cases, GS7
counted 9 cases, GS8 counted 3 cases, GS9 counted 11
cases, and GS10 counted 4 cases.
Table 1 shows the expression of prostate adenocarcinoma
ZIP1 on the level of Gleason score (GS) significant
relationship (p = 0.08). While the expression of Caspase-3
in prostate adenocarcinoma with different GS was found
significantly different (p = 0.841).
In the biomolecular mechanisms, ZIP1 protein acts as a
zinc transporter. Allegedly the increase in protein
expression ZIP1 will increase the expression of the

Caspase-3 protein. To see the relationship between the
protein and Caspase-3 ZIP1 done analysis Pearson
correlation. Results correlation ZIP1 expression and
Caspase-3 in prostate adenocarcinoma can be seen in
Figure 3.
This analysis found a significant positive correlation
between protein expression ZIP1 and Caspase-3 (r = 0.379
and p = 0.018). The higher expression significantly ZIP1
followed by increased expression of Caspase-3. To see
ZIP1 and Caspase-3 protein expression in prostate
adenocarcinoma group of intermediate grade (GS 6-7)
and high grade (GS 8-10) performed women different
analyses; the results are shown in Figure 4. The results
of the statistical calculation obtained analysis results of
the mean ZIP1 protein expression in intermediate-grade,
and high-grade prostate adenocarcinoma did not differ
significantly (p = 0.76), as did the mean Caspase-3 protein
expression in prostate adenocarcinoma in the intermediate
grade and high grade did not differ significantly (p = 0.15).

Table 1. Expression of ZIP1 and Caspase-3 Protein per Group Gleason Score based on the Mean Number of Smear-positive (+)
Cells in Prostate Adenocarcinoma

Prostate adenocarcinoma
(Grade GS)
GS 6
GS 7
GS 8
GS 9
GS 10
mean
p

Number of Case (n)
4
9
3
11
4

Marker Expression
ZIP1
Caspase-3
32.25+2.52
30.50+2.30
28.11+1.87
36.89+2.16
17.00+6.24
23.33+2.15
49.27+2.36
33.91+1.58
31.75+7.13
37.00+1.22
35.55+2.18
33.71+1.80
Kruskal-Walis test = 0.08
ANOVA test = 0.841

2

R Linier = 0.144

80.00

Expression of Cas3

60.00

Correlation
Pearson
40.00

20.00

0.00

r = 0.379; p = 0.018
0.00

20.00

40.00

60.00

80.00

100.00

Expression of Zip1
Figure 3. Graph Correlation ZIP1 Protein and Caspase-3 Protein in Prostate Adenocarcinoma
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Figure 4. Comparison of ZIP1 and Caspase-3 Mean Protein Expression in the Preparation of Prostate Adenocarcinoma
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Figure 5. Graph Correlation ZIP1 Protein and Caspase-3 Protein in Prostate Adenocarcinoma. (a) the Average ZIP1
Correlation with Caspase-3 in the Intermediate Grade (b) the Average Correlation ZIP1 with Caspase-3 in High
Grade (a) The Mean of ZIP1 Expression in Intermediate Grade and High Grade (b) The Mean of Caspase-3 in the
Intermediate Grade and High Grade

Further, analysis of the correlation between protein
expression ZIP1 and Caspase-3 protein on Gleason
Score intermediate grade and high grade shows the
results as shown in Figure 5.
There is a significant positive interaction (r = 0.73,
p = 0.002) between ZIP1 protein expression with
Caspase-3 protein expression in the group of
intermediate grade (GS 6-7), increasing the ZIP1 protein
expression significantly will be followed by increased
the expression of Caspase-3 and in another side, the
group of high-grade (GS 8-10) the relationship between
the expression of ZIP1 protein with Caspase-3 protein
expression is very weak and not significant (r = 0:04,
p = 0:48).
Makara J. Health Res.

Discussion
Studies of cytotoxic or tumour suppressor effects of zinc
in support of a potential zinc treatment approach for
prostate cancer is scattered among many published
reports. Malignant prostate zinc levels are markedly
decreased in all cases of prostate cancer compared to the
normal/benign prostate. ZIP1 zinc transporter down
regulation decreases zinc to prevent its cytotoxic effects.
Thus, prostate cancer is a “ZIP1-deficient” malignancy.5
ZIP1 protein known tobe expressed in several carcinomas
such as prostate and breast carcinoma. In this study, the
positivity ZIP1 on prostate cancer are lower than in
normal prostate. This is in line with research Franklin et
al. which implies positivity ZIP1 in prostate cancer by
April 2016 | Vol. 20 | No. 1
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32% and 75% of normal prostate.6 ZIP1 protein
expression was lower in prostate cancer is thought to
cause lower levels of zinc in prostate carcinoma. This is
because ZIP1 is for the zinc transporter protein that
would cause the loss of the ability of prostate epithelial
cells to accumulate zinc and affect the activity of cell
proliferation so inhibition of apoptotic cells that can
contribute to prostate carcinogenesis.
Decreased ZIP1 expression in prostate adenocarcinoma
associated with epigenetic factors that regulate expression
of the ZIP1 protein.6 This is evidenced by research
Hlavna et al. who stated there was no significant
difference in mRNA expression between normal
prostate cells with prostate cancer.7 Decreased protein
ZIP1 allegedly because of epigenetic factors, that is
deregulation of the post-transcriptional stage that causes
the ZIP1 mRNA not translated into functional proteins.
The epigenetic factors are micro RNA (miRNA) that
involved in the inhibition of ZIP1 protein synthesis. One
of miRNAs that inhibit the ZIP1 expression is
miRNA224. This gene is known to elevate in some
human prostate cancer cell lines. Also, it also inhibits
the expression of micro-RNA metallothionein (MT), the
zinc-binding protein that acts as a buffer and donor zinc
on intracellular processes.7
In this research is also known a decrease in the
expression of Caspase-3 in prostate adenocarcinoma
were suspected because of the post-translational change
break down pro Caspase-3 into Caspase-3. Modification
of proteolytic breakdown of precursor form scan causes
low levels of activated Caspase-3.8 Estrow et al. states
that the low levels of Caspase-3 indicate a poor
prognosis is because most of the Caspase-3, undivided
and unactivated.9 It is thought to be a mechanism of
inhibition of apoptosis that supports the development of
cancer.
Figure 1 shows a significant positive correlation between
ZIP1 and Caspase-3 protein expression. This positive
relationship can be explained by the possibility of
changes in protein expression ZIP1 which has the lead
roles an intracellular zinc transporter, causing changes
in the levels of zinc in cells that trigger the apoptotic
signalling cascade, including changes in the activation
of Caspase-3. Decreased levels of zinc and citrate
occurred starting from the beginning of malignancy.10
Low Zinc levels can also inhibit apoptosis through the
intrinsic cell death pathway. It is characterised by a
decrease in mitochondrial membrane potential, followed
by caspase activation.3 Caspase-3 are present in the
active form can be inhibited by zinc because activation
of catalytic caspase motif consisting of cysteine and
histidine residues can be bound to zinc on one or both
residues the amino acids.11

Makara J. Health Res.

Further, the analysis examines the correlation ZIP1
expression and activity of Caspase-3 in different
Gleason score (Figure 5), showed that there was the
positive correlation in prostate adenocarcinoma group
GS6, 7, and 8. In the GS9 and 10, the relationship is
getting weaker. According to Franklin et al.12 grow than
a development of prostate malignancies caused by the
loss of the ability of prostate cells to accumulate zinc by
decreased expression of the ZIP1 protein. Decreased zinc
plays a role in the inhibition of the formation of
membrane pores Bax combined with a decrease in the
recruitment of cytosolic Bax, resulting in yeast
cytochrome-c is released from mitochondria thus be
reduce apoptotic signalling cascade including decrease in
Caspase-3.10
In this study, also did an analysis of the correlation
between ZIP1 and Caspase-3 expression based Gleason
score grading that is intermediate grade (GS 6 and 7)
and a group of high grade (GS 8-10). The results of the
analysis (Figure 5a) shows a significant positive
correlation (r = 0.73) with linear R2 = 0.544 in the group
of intermediate grade. This means that from the
correlation, 54.4% activation of Caspase-3 is determined
by the expression ZIP1, and other factors determine the
balance. The reverse at the high-grade group, the
correlation is very weak and not significant. Changes in
the expression mechanism are made possible by the
effect of a decrease in zinc levels that have occurred
since the beginning of the development of cancer. Zinc
act as s part of the DNA-binding proteins is known as
zinc finger proteins that act as transcription factors that
bind to short DNA sequences and control the
transcription of various genes.13 Decreased levels of zinc
resulted in the loss of the metal the zinc finger protein.
The loss of zinc in the protein molecule can be replaced
by other metals such as cobalt, cadmium, nickel, and
iron. Replacement of zinc metal zinc finger protein
binds to become one of the causes of carcinogenesis and
DNA damage in cells. Cobalt and iron can cause the
formation of H2O2, which catalyses the degradation of
deoxyribose and induces DNA damage. So that decreased
levels of zinc in prostate adenocarcinoma followed by
molecular replacement zinc other metals are expected to
form free radicals that cause damage to DNA (DNA
mutation).13 The damage (mutations) in the DNA that
occurs adenocarcinoma due to reduced levels of zinc
(ZIP1 reduction effect) thought to have an impact on the
level of malignancy of prostate adenocarcinoma. Highgrade GS group had a higher aggressiveness than the GS
group of intermediate grade. Higher cell aggressiveness
caused DNA mutations that occur in the cell indicated
by the activation of Caspase-3 are no longer affected by
the concentration of zinc in cells.
Despite decades of research, no efficacious chemotherapy
exists for the treatment of prostate cancer. A zinc
April 2016 | Vol. 20 | No. 1
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ionophore (e.g. Clioquinol) treatment to increase malignant
zinc levels is a plausible treatment for prostate cancer.5
This research can be useful in supporting the determination
of the dose of zinc ionophore treatment.

4.

5.

Conclusions
It was concluded that ZIP1 protein expression and
Caspase-3 was not correlated with the Gleason Score,
but it is also known is a positive relationship between
the expression of Caspase-3 and ZIP1 with the
adenocarcinoma of the prostate.
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